REQUEST A DEMO
Total
USD $0.00
Search more companies

Ilsung Pharmaceuticals Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Ilsung Pharmaceuticals Co.,Ltd. Profile Updated: July 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Ilsung Pharmaceuticals Co.,Ltd. is engaged in manufacturing, supply and distribution of pharmaceutical products. The company offers antibiotics, diagnostics including contrast media, and the products for cardiovascular, GI tract, metabolism disorders, ophthalmological disorders, and inhalation anesthetics. Ilsung Pharmaceuticals Co.,Ltd. is based in Seoul, South Korea. The company was incorporated in 1961.

Headquarters
44-7 Wonhyoro-1-Ga, Yongsan-Gu
Seoul; Seoul; Postal Code: 140-111

Contact Details: Purchase the Ilsung Pharmaceuticals Co.,Ltd. report to view the information.

Website: http://www.ilsung-ph.co.kr

Basic Information
Total Employees:
Purchase the Ilsung Pharmaceuticals Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Ilsung Pharmaceuticals Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Ilsung Pharmaceuticals Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Ilsung Pharmaceuticals Co.,Ltd. report to view the information.
Incorporation Date:
February 15, 1961
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
8.44%
Purchase this report to view the information.
8.03%
Purchase this report to view the information.
5.01%
Purchase this report to view the information.
0.23%
Purchase this report to view the information.
0.23%
Subsidiaries
Tv조선
1%
NH Investment & Securities Co., Ltd. (Seoul)
0.07%
매일방송
0.07%
Company Performance
Financial values in the chart are available after Ilsung Pharmaceuticals Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
89.82%
Total operating revenue
84.9%
Operating profit (EBIT)
-764.1%
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
23.59%
Total equity
22.52%
Operating Profit Margin (ROS)
-9.68%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-0.01%
Quick Ratio
-0.77%
Cash Ratio
7.77%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?